Industry Analysis & Industry Trends
Brand name pharmaceutical manufacturers have grappled in recent years with one of the largest waves of drug patent expirations in history. As this so-called patent cliff occurred, many blockbuster drugs lost patent exclusivity, allowing low-price generic drugs to inundate the market. As a result, many brand name pharmaceutical manufacturers have contended with intensifying competition from generic manufacturers. In the coming years, brand-name pharmaceutical manufacturers will exhibit growth due to strong consumer demand for biologic drugs... purchase to read more
Industry Report - Industry Investment Chapter
The Brand Name Pharmaceutical Manufacturing industry is moderately capital intensive. Pharmaceutical manufacturing requires research laboratories and facilities, manufacturing machinery as well as other technology and equipment, which add to capital costs. However, wage costs are also high as this industry requires skilled labor to provide value-added services. For example, pharmaceutical researchers, scientists, technicians and laboratory assistants typically have considerable education and training, thus resulting in a high average wage. In 2016, for every dollar spent on labor, an estimated $0.29 is spent on capital.
Over the past five years, capital expenditures have moderately declined and are expected to continue steadily falling over the next five years... purchase to read more